Net income of Edwards Lifesciences under GAAP for the 3 months of 2022 was $373.6 million, up 10.5% from $338.2 million in the previous year. Revenue increased 10.2% to $1.341 billion from $1.217 billion a year earlier.
Net income of Edwards Lifesciences under GAAP for the 3 months of 2022 was $373.6 million, up 10.5% from $338.2 million in the previous year. Revenue increased 10.2% to $1.341 billion from $1.217 billion a year earlier. 
ir.edwards.com
English (US) 